Jan 27 (Reuters) - The U.S. government on ‌Tuesday named the 15 new drugs targeted ‌for Medicare price negotiations for 2028, including Gilead Sciences' HIV drug Biktarvy and Pfizer's arthritis ...
Add Yahoo as a preferred source to see more of our stories on Google. This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results